9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Kuroki, H. ; Anraku, T. ; Bilim, V. ; Tasaki, M. ; Schmitt, D. ; Mazar, A. ; Ugolkov, A. ; Tomita, Y.

Annals of oncology, 2018-10, Vol.29, p.viii9-viii9 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível